Literature DB >> 30246669

Decision-making ability in psychosis: a systematic review and meta-analysis of the magnitude, specificity and correlates of impaired performance on the Iowa and Cambridge Gambling Tasks.

Amanda Woodrow1, Sarah Sparks2, Valeria Bobrovskaia2, Charlotte Paterson1, Philip Murphy1, Paul Hutton1.   

Abstract

To identify factors which may help or hinder decision-making ability in people with psychosis, we did a systematic review and meta-analysis of their performance on the Iowa and Cambridge Gambling Tasks. Analysis of 47 samples found they had moderately poorer performance than healthy individuals (N = 4264, g = -0.57, 95% confidence interval (CI) -0.66 to -0.48). Few studies (k = 8) used non-psychotic clinical comparator groups, although very low-quality evidence (k = 3) found people with bipolar disorder may perform better. Negative symptoms (k = 13, N = 648, r = -0.17, 95% CI -0.26 to -0.07) and lower IQ (k = 11, N = 525, r = 0.20, 95% CI 0.29-0.10), but not positive symptoms (k = 10, N = 512, r = -0.01, 95% CI -0.11 to 0.08), each had small-moderate associations with poorer decision-making. Lower quality evidence suggested general symptoms, working memory, social functioning, awareness of emotional responses to information, and attentional bias towards gain are associated with decision-making, but not education, executive functioning or overall symptoms. Meta-regression suggested an inverse association between decision-making and depression severity (k = 6, Q = 6.41, R2 100%, p = 0.01). Those taking first-generation (k = 6, N = 305, g = -0.17, 95% CI -0.40 to 0.06, p = 0.147) or low-dose antipsychotics (k = 5, N = 442, g = -0.19, 95% CI -0.44 to 0.06, p = 0.139) had unimpaired decision-making. Although meta-regression found no linear association between dose and performance, non-reporting of the dose was common and associated with larger impairments (k = 46, Q = 4.71, R2 14%, p = 0.03). Those supporting people with psychosis to make decisions, including treatment decisions, should consider the potential effect of these factors. Interventionist-causal trials are required to test whether reducing antipsychotic dose and treating anxiety and depression can improve decision-making in this group.

Entities:  

Keywords:  Decision making; Iowa gambling task; meta-analysis; psychosis; schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 30246669     DOI: 10.1017/S0033291718002660

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  8 in total

1.  Mediating role of impaired wisdom in the relation between childhood trauma and psychotic-like experiences in Chinese college students: a nationwide cross-sectional study.

Authors:  Jiamei Zhang; Zhening Liu; Yicheng Long; Haojuan Tao; Xuan Ouyang; Guowei Wu; Min Chen; Miaoyu Yu; Liang Zhou; Meng Sun; Dongsheng Lv; Guangcheng Cui; Qizhong Yi; Hong Tang; Cuixia An; Jianjian Wang; Zhipeng Wu
Journal:  BMC Psychiatry       Date:  2022-10-21       Impact factor: 4.144

2.  Decision-making and risk-taking in forensic and non-forensic patients with schizophrenia spectrum disorders: A multicenter European study.

Authors:  Laura Iozzino; Nicola Canessa; Paola Rucci; Marica Iommi; Alexander Dvorak; Janusz Heitzman; Inga Markiewicz; Marco Picchioni; Anna Pilszyk; Johannes Wancata; Giovanni de Girolamo
Journal:  Schizophr Res Cogn       Date:  2022-05-19

3.  A meta-review of literature reviews assessing the capacity of patients with severe mental disorders to make decisions about their healthcare.

Authors:  A Calcedo-Barba; A Fructuoso; J Martinez-Raga; S Paz; M Sánchez de Carmona; E Vicens
Journal:  BMC Psychiatry       Date:  2020-06-30       Impact factor: 3.630

4.  Changes in Loss Sensitivity During Treatment in Concurrent Disorders Inpatients: A Computational Model Approach to Assessing Risky Decision-Making.

Authors:  Stefanie Todesco; Thomas Chao; Laura Schmid; Karina A Thiessen; Christian G Schütz
Journal:  Front Psychiatry       Date:  2022-01-28       Impact factor: 4.157

5.  Decisional capacity in young people with first episode psychosis, major depressive disorder and no mental disorder.

Authors:  Chiara M J Killey; Kelly Allott; Sarah Whitson; Shona M Francey; Christina Bryant; Magenta B Simmons
Journal:  Schizophr Res Cogn       Date:  2021-12-08

6.  Altered risky decision making in patients with early non-affective psychosis.

Authors:  Luk Msk; Chang Wc; Chong Csy; Siu Cmw; Chan Skw; Lee Emh; Hui Clm; Sun Yn; Lee Tmc; Lo Tl; Chen Eyh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-02-26       Impact factor: 5.270

7.  Intermittent Theta Burst Stimulation (iTBS) as an Optimal Treatment for Schizophrenia Risk Decision: an ERSP Study.

Authors:  Yang Wu; Lu Wang; Fengqiong Yu; Gong-Jun Ji; Guixian Xiao; Xu Feifei; Zhu Chunyan; Chen Xingui; Kai Wang
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

8.  The schizophrenia risk gene Map2k7 regulates responding in a novel contingency-shifting rodent touchscreen gambling task.

Authors:  Rebecca L Openshaw; Judith A Pratt; Brian J Morris
Journal:  Dis Model Mech       Date:  2022-03-11       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.